CHEMBIO DIAGNOSTICS, INC. Asset Impairment Charges
CHEMBIO DIAGNOSTICS, INC. reported Asset Impairment Charges of $3.03 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AssetImpairmentCharges · last filed 2023-03-29
- CHEMBIO DIAGNOSTICS, INC. asset impairment charges for the quarter ending 2022-03-31 was $3.00M.
- CHEMBIO DIAGNOSTICS, INC. asset impairment charges for the quarter ending 2021-12-31 was $4.61M.
- CHEMBIO DIAGNOSTICS, INC. asset impairment charges for the quarter ending 2021-09-30 was $0.00.
- CHEMBIO DIAGNOSTICS, INC. asset impairment charges for the quarter ending 2021-06-30 was $1.30M.
- CHEMBIO DIAGNOSTICS, INC. asset impairment charges for fiscal 2022 was $3.03M, a 48.42% decline from fiscal 2021.
- CHEMBIO DIAGNOSTICS, INC. asset impairment charges for fiscal 2021 was $5.88M.
- CHEMBIO DIAGNOSTICS, INC. asset impairment charges for fiscal 2020 was $0.00.
| Period end | Asset Impairment Charges 3 month | Asset Impairment Charges 3 month as first filed | Asset Impairment Charges 6 month | Asset Impairment Charges 9 month | Asset Impairment Charges 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | $3.03M 10-K · filed 2023-03-29 | ||||
| 2022-03-31 | $3.00M 10-K · filed 2023-03-29 | $7.61M derived: sum of 2 quarters · filed 2023-03-29 | $7.61M derived: sum of 3 quarters · filed 2023-03-29 | $8.91M derived: sum of 4 quarters · filed 2023-03-29 | |
| 2021-12-31 | $4.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $4.61M derived: sum of 2 quarters · filed 2023-03-29 | $5.91M derived: sum of 3 quarters · filed 2023-03-29 | $5.88M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-05 | $1.30M derived: sum of 2 quarters · filed 2022-03-03 | $1.27M 10-Q · filed 2021-11-05 | ||
| 2021-06-30 | $1.30M 10-K · filed 2022-03-03 | $1.27M 10-Q · filed 2021-08-09 | $1.27M 10-Q · filed 2021-08-09 | ||
| 2020-12-31 | $0.00 10-K · filed 2022-03-03 |